Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients

BACKGROUND: The presence of significant liver fibrosis in hepatitis B virus (HBV)-infected individuals with persistently normal serum alanine aminotransferase (PNALT) levels is a strong indicator for initiating antiviral therapy. Serum ceruloplasmin (CP) is negatively correlated with liver fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Na-Ling, Zhang, Jie-Min, Lin, Meng-Xin, Chen, Xu-Dong, Huang, Zu-Xiong, Zhu, Yue-Yong, Liu, Yu-Rui, Zeng, Da-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385565/
https://www.ncbi.nlm.nih.gov/pubmed/32774069
http://dx.doi.org/10.3748/wjg.v26.i27.3952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385565/
https://www.ncbi.nlm.nih.gov/pubmed/32774069
http://dx.doi.org/10.3748/wjg.v26.i27.3952

Ejemplares similares